![Immuno-Oncology Research]( "Immuno-Oncology Research")
Immuno-Oncology Research
Advancing & Accelerating
Your Immuno-Oncology
Research
Immuno-oncology (cancer immunotherapy), describes the process of
utilizing the patient's own immune system to fight cancer. In the
last decade, immuno-oncology has emerged as an exciting new approach
to cancer treatment because of its specificity, adaptability and
durability. One of the key areas within this field is a new class of
proteins called immune checkpoints, such as PD-1 and CTLA-4 among
others, which could enable cancer cells to hide from the immune
system by modulating T cell signaling. Immune-checkpoints are being
studied extensively as a new type of targets for cancer
immunotherapy.
GenScript provides the One-Stop Platform to accelerate your
immuno-oncology research, including numerous neutralizing immune
checkpoint antibodies and anti-idiotypes (IDs), stable cell lines
expressing immuno-oncology proteins at high levels, a wide range of
purified recombinant proteins involved in immuno-signaling pathways,
together with assay platforms for drug discovery and development.
GenScript provides multifunctional immune
checkpoint antibody products to facilitate your
immunotherapy research.
The high-quality Immune Checkpoint Proteins in
GenScript can support many kinds of researches
in immune-oncology field.
Stable Cell Lines for Immuno-Oncology Research
(CellPower™)
Both immune checkpoints and oncogene
expressed stable cell lines are supplied;
By implementing strict QC standards, GenScript
provides the assurance of the efficacy and
potency profiles of your therapeutic antibodies.
Support PK and immunogenicity study of
biosimilars.
Most Popular Products
CRISPR Gene Editing
Antibodies
Protein Electrophoresis and Blotting
Molecular Biology
Stable Cell Lines
Cell Therapy
Diagnostics
Resources
